A more complete molecular picture of lung squamous cell carcinoma comes into view: New insights into lung tumor biology and potential drug targets emerge from a study integrating genomics and proteomics
Lung cancer remains the leading cause of cancer-associated death in the United States and worldwide. Patients with a subtype called lung adenocarcinoma (LUAD) have benefited from the development of new targeted medicines, but the search for effective new therapies for another subtype called lung squamous cell carcinoma (LSCC) has largely come up short. To learn […]